OncoSec Medical Inc.
200 South Virginia Street
8th Floor
Reno
Nevada
89501
United States
Tel: 775-562-0504
Website: http://www.oncosec.com/
Email: investors@oncosec.com
410 articles about OncoSec Medical Inc.
-
OncoSec Medical Inc. To Present At 24th Annual Wall Street Analyst Forum Institutional Investor Conference
2/25/2014
-
OncoSec Medical Inc. To Present At 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/4/2014
-
OncoSec Medical Inc. Announces 2014 Strategic Update
1/14/2014
-
OncoSec Medical Inc. To Present At “TEN”; Noble Financial Capital Markets’ Tenth Annual Equity Conference
1/13/2014
-
OncoSec Medical Inc. To Present Corporate Update At Biotech Showcase 2014
1/7/2014
-
OncoSec Medical Inc. Announces Positive Interim Data From Phase 2 Study Of OMS-I100 In Metastatic Melanoma
12/16/2013
-
OncoSec Medical Inc. Announces Positive Interim Data From Phase 2 Study Of OMS-I100 In Metastatic Melanoma
12/16/2013
-
OncoSec Medical Inc. Announces Hire Of Chief Medical Officer
12/12/2013
-
OncoSec Medical Inc. To Present At The 6th Annual LD Micro Conference
11/26/2013
-
OncoSec Medical Inc. Announces Positive Preliminary Safety Data in Combination Study
10/8/2013
-
OncoSec Medical Inc. CEO Punit Dhillon to Present at INTERFACE 2013 Digital Health Summit
10/4/2013
-
OncoSec Medical Inc. to Present at the 12th Annual Biotechnology Industry Organization (BIO) Investor Forum
10/3/2013
-
OncoSec Medical Inc. to Present at the Cancer Vaccines and Gene Therapy Meeting
10/1/2013
-
OncoSec Medical Inc. to Present at the 2013 Aegis Capital Healthcare Conference
9/20/2013
-
OncoSec Medical Inc. Announces $12 Million Public Offering
9/16/2013
-
OncoSec Medical Inc. to Present at the 15th Annual Rodman & Renshaw Global Investment Conference
9/4/2013
-
OncoSec Medical Inc. Presents Positive Immune Response Data from Phase II Study at the 8th World Congress of Melanoma
7/22/2013
-
OncoSec Medical Inc. Featured on San Francisco’s KGO-TV Channel 7
7/19/2013
-
OncoSec Medical Inc. Announces Completion of Enrollment of Phase II Metastatic Melanoma Trial
6/18/2013
-
OncoSec Medical Inc. Enters Sponsored Research Agreement With Old Dominion University for Combination Study in Melanoma
6/11/2013